Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018.

Bluemel B, Goelz H, Goldmann B, Grüger J, Hamel H, Loley K, Ludolph T, Meyer J, Miehlke S, Mohr A, Tüffers K, Usadel H, Wagner S, Wenzel H, Wiemer L, Vorreiter J, Eisele B, Hofreuter D, Glocker EO.

Clin Microbiol Infect. 2019 Jun 15. pii: S1198-743X(19)30314-3. doi: 10.1016/j.cmi.2019.06.007. [Epub ahead of print]

PMID:
31212078
2.

Clinical management of eosinophilic esophagitis - a nationwide survey among gastroenterologists in Germany.

Miehlke S, von Arnim U, Schlag C, Frieling T, Madisch A, Loibl R, Mainz D, Labenz J.

Z Gastroenterol. 2019 Jun;57(6):745-752. doi: 10.1055/a-0885-1963. Epub 2019 Jun 6.

PMID:
31170743
3.

S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.

Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:.

Z Gastroenterol. 2019 Mar;57(3):e120. doi: 10.1055/a-0884-5474. Epub 2019 Apr 5. German. No abstract available.

PMID:
30952167
4.

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, Bredenoord AJ, Ciriza de Los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A; International EOS-1 Study Group.

Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.

5.

S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.

Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:.

Z Gastroenterol. 2019 Mar;57(3):336-418. doi: 10.1055/a-0833-5712. Epub 2019 Mar 12. German. No abstract available. Erratum in: Z Gastroenterol. 2019 Mar;57(3):e120.

PMID:
30861559
Free Article
6.

Microscopic colitis: pathophysiology and clinical management.

Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):305-314. doi: 10.1016/S2468-1253(19)30048-2. Review.

PMID:
30860066
7.

Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.

Schmelz R, Miehlke S, Thiede C, Brueckner S, Dawel M, Kuhn M, Ruskoné-Formestraux A, Stolte M, Jentsch C, Hampe J, Morgner A.

J Gastroenterol. 2019 May;54(5):388-395. doi: 10.1007/s00535-018-1517-4. Epub 2018 Oct 16.

PMID:
30327875
8.

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.

Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group.

Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7.

9.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ.

Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6. Review.

10.

Efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in a real‑world setting - results from a German noninterventional study.

Andresen V, Miehlke S, Beck E, Wiseman G, Layer P.

Z Gastroenterol. 2018 Jul;56(7):738-744. doi: 10.1055/s-0043-124875. Epub 2018 May 9.

PMID:
29742779
11.

Effectiveness of Menthacarin on symptoms of irritable bowel syndrome.

Madisch A, Miehlke S, Labenz J, Stracke B, Köhler S.

Wien Med Wochenschr. 2019 Apr;169(5-6):149-155. doi: 10.1007/s10354-018-0635-1. Epub 2018 May 4.

12.

Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician.

Miehlke S, Acosta MB, Bouma G, Carpio D, Magro F, Moreels T, Probert C.

J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14151. [Epub ahead of print] Review.

PMID:
29603368
13.

[Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS].

Miehlke S, Schlag C, Storr M, Arnim UV.

Z Gastroenterol. 2018 Feb;56(2):139-150. doi: 10.1055/s-0043-121349. Epub 2017 Nov 9. German.

PMID:
29121691
14.

Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.

Miehlke S, Frederking D, Günther T, Glocker E, Eisele B, Andresen V, Schröder S, Morgner A.

Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12429. Epub 2017 Aug 22.

PMID:
28833925
15.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE.

United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23. Review.

16.

Azathioprine allows glucocorticoid withdrawal - post hoc results of a prospective study in patients with inflammatory bowel diseases.

Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Siegmund B, Schmidt C, Stallmach A; German IBD Study group.

Z Gastroenterol. 2017 May;55(5):461-465. doi: 10.1055/s-0043-106310. Epub 2017 May 12.

PMID:
28499322
17.

[S2k guideline Helicobacter pylori and gastroduodenal ulcer disease 2016 - Statement on stress ulcer prophylaxis and optimized therapy].

Hoffmann JC, Prinz C, Labenz J, Miehlke S, Malfertheiner P, Fischbach W.

Z Gastroenterol. 2017 Mar;55(3):307-309. doi: 10.1055/s-0043-100103. Epub 2017 Mar 13. German. No abstract available.

PMID:
28288502
18.

Letter: multivariate clinical model for eosinophilic oesophagitis - is this generalisable to a general population? Authors' reply.

von Arnim U, Röhl FW, Miehlke S, Jechorek D, Reinhold D, Wex T, Malfertheiner P.

Aliment Pharmacol Ther. 2017 Mar;45(6):861. doi: 10.1111/apt.13967. No abstract available.

19.

[Eosinophilic Esophagitis - Update - Pathogenesis, Diagnosis and Therapy].

von Arnim U, Miehlke S, Madisch A, Vieth M, Straumann A, Malfertheiner P.

Laryngorhinootologie. 2017 Jan;96(1):11-21. doi: 10.1055/s-0042-119417. Epub 2017 Feb 13. German.

PMID:
28192821
20.

Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis.

von Arnim U, Röhl FW, Miehlke S, Jechorek D, Reinhold D, Wex T, Malfertheiner P.

Aliment Pharmacol Ther. 2017 Feb;45(3):417-426. doi: 10.1111/apt.13869. Epub 2016 Nov 29.

21.

[Diagnostic and therapeutic management of helicobacter pylori: a survey among German gastroenterologists in private practice].

Miehlke S, Loibl R, Meszaros S, Labenz J.

Z Gastroenterol. 2016 Oct;54(10):1130-1137. Epub 2016 Oct 10. German.

PMID:
27723904
22.

Superiority of a Split-dose Regimen of Sodium Picosulfate/Magnesium Citrate (SPMC) in Comparison to a Prior-day Schedule (AM/PM) for Colonoscopy Preparation. A Randomized Single-blinded Study.

Schulz C, Müller J, Sauter J, Miehlke S, Schmöcker C, Hartmann D, Malfertheiner P, Badiola C.

J Gastrointestin Liver Dis. 2016 Sep;25(3):295-302. doi: 10.15403/jgld.2014.1121.253.mag.

23.

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann JC, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M; Verantwortlich für die DGVS.

Z Gastroenterol. 2016 Apr;54(4):327-63. German. No abstract available. Erratum in: Z Gastroenterol. 2016 Apr;54(4):1.

PMID:
27512738
24.

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann CJ, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M; Verantwortlich für die DGVS.

Z Gastroenterol. 2016 Apr;54(4):1. doi: 10.1055/s-0035-1567086. Epub 2016 May 11. German.

25.

Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis.

von Arnim U, Wex T, Link A, Messerschmidt M, Venerito M, Miehlke S, Malfertheiner P.

Aliment Pharmacol Ther. 2016 Apr;43(7):825-30. doi: 10.1111/apt.13560. Epub 2016 Feb 22.

26.

Smoking Status Influences Clinical Outcome in Collagenous Colitis.

Münch A, Tysk C, Bohr J, Madisch A, Bonderup OK, Mohrbacher R, Mueller R, Greinwald R, Ström M, Miehlke S.

J Crohns Colitis. 2016 Apr;10(4):449-54. doi: 10.1093/ecco-jcc/jjv235. Epub 2015 Dec 30.

27.

S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0 - September 2015, AWMF-Registernummer: 021/023OL).

Porschen R, Buck A, Fischbach W, Gockel I, Görling U, Grenacher L, Hollerbach S, Hölscher A, Körber J, Messmann H, Meyer HJ, Miehlke S, Möhler M, Nöthlings U, Pech U, Schmidberger H, Schmidt M, Stahl M, Stuschke M, Thuss-Patience P, Trojan J, Vanhoefer U, Weimann A, Wenz F, Wullstein C.

Z Gastroenterol. 2015 Nov;53(11):1288-347. doi: 10.1055/s-0041-107381. Epub 2015 Nov 12. German. No abstract available.

28.

Clinical features of Eosinophilic esophagitis in children and adults.

Miehlke S.

Best Pract Res Clin Gastroenterol. 2015 Oct;29(5):739-748. doi: 10.1016/j.bpg.2015.09.005. Epub 2015 Sep 10. Review.

PMID:
26552773
29.

Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.

Westerlind H, Mellander MR, Bresso F, Munch A, Bonfiglio F, Assadi G, Rafter J, Hübenthal M, Lieb W, Källberg H, Brynedal B, Padyukov L, Halfvarson J, Törkvist L, Bjork J, Andreasson A, Agreus L, Almer S, Miehlke S, Madisch A, Ohlsson B, Löfberg R, Hultcrantz R, Franke A, D'Amato M.

Gut. 2017 Mar;66(3):421-428. doi: 10.1136/gutjnl-2015-309934. Epub 2015 Nov 2.

PMID:
26525574
30.

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.

Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Klugmann T, Kruis W, Siegmund B, Helwig U, Weismüller J, Drabik A, Stallmach A; German IBD Study Group.

J Crohns Colitis. 2016 Jan;10(1):61-8. doi: 10.1093/ecco-jcc/jjv188. Epub 2015 Oct 13.

31.

Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.

Schlag C, Miehlke S, Heiseke A, Brockow K, Krug A, von Arnim U, Straumann A, Vieth M, Bussmann C, Mueller R, Greinwald R, Bajbouj M.

Aliment Pharmacol Ther. 2015 Nov;42(9):1122-30. doi: 10.1111/apt.13386. Epub 2015 Aug 27.

32.

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A.

Gut. 2016 Mar;65(3):390-9. doi: 10.1136/gutjnl-2014-308815. Epub 2015 Mar 19.

33.

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Münch A, Bohr J, Miehlke S, Benoni C, Olesen M, Öst Å, Strandberg L, Hellström PM, Hertervig E, Armerding P, Stehlik J, Lindberg G, Björk J, Lapidus A, Löfberg R, Bonderup O, Avnström S, Rössle M, Dilger K, Mueller R, Greinwald R, Tysk C, Ström M; BUC-63 investigators.

Gut. 2016 Jan;65(1):47-56. doi: 10.1136/gutjnl-2014-308363. Epub 2014 Nov 25.

34.

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).

Schmelz R, Bornhäuser M, Schetelig J, Kiani A, Platzbecker U, Schwanebeck U, Grählert X, Uharek L, Aust D, Baretton G, Schwerdtfeger R, Hampe J, Greinwald R, Mueller R, Ehninger G, Miehlke S.

BMC Gastroenterol. 2014 Nov 26;14:197. doi: 10.1186/s12876-014-0197-7.

35.

[S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013].

Koop H, Fuchs KH, Labenz J, Lynen Jansen P, Messmann H, Miehlke S, Schepp W, Wenzl TG; Mitarbeiter der Leitliniengruppe.

Z Gastroenterol. 2014 Nov;52(11):1299-346. doi: 10.1055/s-0034-1385202. Epub 2014 Nov 12. German. No abstract available.

36.

Histology of microscopic colitis-review with a practical approach for pathologists.

Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A; Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG).

Histopathology. 2015 Apr;66(5):613-26. doi: 10.1111/his.12592. Epub 2015 Jan 12. Review.

PMID:
25381724
37.

[Microscopic colitis: clinical presentation, treatment and outcome of 494 patients].

Madisch A, Miehlke S, Bartosch F, Bethke B, Stolte M.

Z Gastroenterol. 2014 Sep;52(9):1062-5. doi: 10.1055/s-0034-1366281. Epub 2014 Sep 8. German.

PMID:
25198085
38.

[Eosinophilic esophagitis - update - pathogenesis, diagnosis and therapy].

von Arnim U, Miehlke S, Madisch A, Vieth M, Straumann A, Malfertheiner P.

Z Gastroenterol. 2014 Mar;52(3):296-305. doi: 10.1055/s-0033-1356135. Epub 2014 Mar 12. Review. German.

PMID:
24622873
39.

Clinical features of eosinophilic esophagitis.

Miehlke S.

Dig Dis. 2014;32(1-2):61-7. doi: 10.1159/000357011. Epub 2014 Feb 28. Review.

40.

[Eosinophilic esophagitis].

Miehlke S.

Dtsch Med Wochenschr. 2014 Feb;139(6):272-4. doi: 10.1055/s-0033-1359965. Epub 2014 Jan 28. German. No abstract available.

PMID:
24473847
41.

Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.

Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK; BUC-60/COC Study Group.

Gastroenterology. 2014 May;146(5):1222-30.e1-2. doi: 10.1053/j.gastro.2014.01.019. Epub 2014 Jan 15.

42.

Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy.

Miehlke S, Hansen JB, Madisch A, Schwarz F, Kuhlisch E, Morgner A, Teglbjaerg PS, Vieth M, Aust D, Bonderup OK.

Inflamm Bowel Dis. 2013 Dec;19(13):2763-7. doi: 10.1097/01.MIB.0000438135.88681.98.

PMID:
24216688
43.

Induction of eosinophilic esophagitis by sublingual pollen immunotherapy.

Miehlke S, Alpan O, Schröder S, Straumann A.

Case Rep Gastroenterol. 2013 Sep 3;7(3):363-8. doi: 10.1159/000355161. eCollection 2013.

44.

[Microscopic colitis--new insights relevant to clinical practice].

Miehlke S, Aust D, Madisch A.

Z Gastroenterol. 2013 Dec;51(12):1389-94. doi: 10.1055/s-0033-1355518. Epub 2013 Oct 21. Review. German.

PMID:
24146102
45.

[Successful treatment of Lichen planus esophagitis with topical budesonide].

Miehlke S, Reinhold B, Schröder S.

Z Gastroenterol. 2012 Oct;50(10):1104-7. doi: 10.1055/s-0032-1312979. Epub 2012 Oct 11. German.

PMID:
23059805
46.

Oral immunotherapy for egg allergy in children.

Alpan O, Miehlke S, Straumann A.

N Engl J Med. 2012 Oct 11;367(15):1472; author reply 1472-3. doi: 10.1056/NEJMc1209949. No abstract available.

PMID:
23050541
47.

Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group.

Münch A, Aust D, Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, Madisch A, Munck LK, Ström M, Tysk C, Miehlke S; European Microscopic Colitis Group (EMCG).

J Crohns Colitis. 2012 Oct;6(9):932-45. Epub 2012 Jun 15. Review.

48.

Probe-based confocal laser endomicroscopy in double balloon enteroscopy.

Miehlke S, Morgner A, Aust D, Baretton G, Madisch A.

Z Gastroenterol. 2011 Jul;49(12):1529-34. doi: 10.1055/s-0031-1282025. Epub 2011 Dec 2.

PMID:
22139876
49.

Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.

Miehlke S, Krasz S, Schneider-Brachert W, Kuhlisch E, Berning M, Madisch A, Laass MW, Neumeyer M, Jebens C, Zekorn C, Knoth H, Vieth M, Stolte M, Lehn N, Morgner A.

Helicobacter. 2011 Dec;16(6):420-6. doi: 10.1111/j.1523-5378.2011.00867.x.

PMID:
22059392
50.

[Current value of quinolones in Helicobacter pylori therapy].

Krasz S, Miehlke S, Berning M, Morgner A, Labenz J.

Z Gastroenterol. 2011 Aug;49(8):989-96. doi: 10.1055/s-0031-1273390. Epub 2011 Aug 2. Review. German.

PMID:
21811951

Supplemental Content

Loading ...
Support Center